Muscular Dystrophy Association

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1159/000369343 Prevalence of Muscular Dystrophies: A Systematic Literature Review
https://doi.org/10.1056/nejm198905183202001 Mitochondrial DNA Deletions in Progressive External Ophthalmoplegia and Kearns-Sayre Syndrome
https://doi.org/10.1016/0092-8674(93)90058-x DNA deletion associated with hereditary neuropathy with liability to pressure palsies
https://doi.org/10.1038/344540a0 Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3
https://doi.org/10.1038/nm1085 Systemic delivery of genes to striated muscles using adeno-associated viral vectors
https://doi.org/10.1378/chest.112.4.1024 Prevention of Pulmonary Morbidity for Patients With Duchenne Muscular Dystrophy
https://doi.org/10.1002/ana.24555 Longitudinal effect of eteplirsen versus historical control on ambulation in D uchenne muscular dystrophy
https://doi.org/10.1038/nm1345 Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
https://doi.org/10.1212/wnl.52.8.1658 A 10-year study of mortality in a cohort of patients with myotonic dystrophy
https://doi.org/10.1016/0960-8966(92)90045-8 MELAS: An original case and clinical criteria for diagnosis
https://doi.org/10.1038/nm1439 rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
https://doi.org/10.1126/scitranslmed.aan8081 Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
https://doi.org/10.1038/s41467-018-05843-9 Cas9 immunity creates challenges for CRISPR gene editing therapies
https://doi.org/10.1056/nejmoa070174 Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis
https://doi.org/10.3233/jnd-180304 Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
https://doi.org/10.1038/s41556-017-0010-2 ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs
https://doi.org/10.1038/mt.2008.103 Recombinant Adeno-associated Virus Transduction and Integration
https://doi.org/10.1016/j.bbadis.2006.05.013 Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
https://doi.org/10.1378/chest.07-0458 American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation
https://doi.org/10.1083/jcb.201006025 MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3
https://doi.org/10.1212/wnl.0000000000003217 Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy
https://doi.org/10.1002/mus.23942 Cost of illness for neuromuscular diseases in the United States
https://doi.org/10.1002/mus.23831 Corticosteroids in Duchenne muscular dystrophy: Major variations in practice
https://doi.org/10.1093/hmg/ddz181 Spp1 (osteopontin) promotes TGFβ processing in fibroblasts of dystrophin-deficient muscles through matrix metalloproteinases
https://doi.org/10.1371/journal.pone.0097803 Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial
https://doi.org/10.4300/jgme-d-18-00979.3 A Narrative Review of the Evidence Supporting Factors Used by Residency Program Directors to Select Applicants for Interviews
https://doi.org/10.1002/humu.23561 DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype
https://doi.org/10.3109/17482960903358865 Toward more efficient clinical trials for amyotrophic lateral sclerosis
https://doi.org/10.1111/ene.16229 Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
https://doi.org/10.1089/hum.2012.208 Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer
https://doi.org/10.1038/s41586-024-07710-8 Split intein-mediated protein trans-splicing to express large dystrophins
https://doi.org/10.2217/bmm-2018-0125 Cardiac MRI biomarkers for Duchenne muscular dystrophy
https://doi.org/10.3233/jnd-221639 Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’
https://doi.org/10.1038/s42003-022-03938-0 Single nuclei transcriptomics of muscle reveals intra-muscular cell dynamics linked to dystrophin loss and rescue
https://doi.org/10.1172/jci171235 Spliceosome malfunction causes neurodevelopmental disorders with overlapping features
https://doi.org/10.1016/j.asj.2008.04.009 Lipodystrophy in the Patient with HIV: Social, Psychological, and Treatment Considerations
https://doi.org/10.1038/s41582-024-00961-z The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
https://doi.org/10.1038/s41467-022-34694-8 Impaired mitochondrial oxidative metabolism in skeletal progenitor cells leads to musculoskeletal disintegration
https://doi.org/10.1074/jbc.m111.271767 Absence of Post-phosphoryl Modification in Dystroglycanopathy Mouse Models and Wild-type Tissues Expressing Non-laminin Binding Form of α-Dystroglycan
https://doi.org/10.1111/resp.12836 Effects of positive end expiratory pressure administration during non‐invasive ventilation in patients affected by amyotrophic lateral sclerosis: A randomized crossover study
https://doi.org/10.18071/isz.76.0005 Characteristics of stroke-like lesions on cerebral imaging
https://doi.org/10.1212/wnl.0000000000213604 Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus
https://doi.org/10.1001/jamaneurol.2019.1206 Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening
https://doi.org/10.1016/j.cell.2024.08.047 Saturation mutagenesis-reinforced functional assays for disease-related genes
https://doi.org/10.1016/j.omtn.2025.102759 Genetic strategies for therapy of Duchenne muscular dystrophy
https://doi.org/10.1073/pnas.2515267122 Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease
https://doi.org/10.1212/wnl.0000000000214291 Expert Consensus on Genetic Diagnostic Approaches for Patients With Limb-Girdle Muscular Dystrophy
https://doi.org/10.1016/0960-8966(93)90040-q Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA
https://doi.org/10.1056/nejm199307223290404 Molecular Genetic Heterogeneity of Myophosphorylase Deficiency (McArdle's Disease)
https://doi.org/10.1016/0960-8966(94)00079-o A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene
https://doi.org/10.1016/s0278-2391(03)00668-2 Office-based ambulatory anesthesia: outcomes of clinical practice of oral and maxillofacial surgeons
https://doi.org/10.1093/ptj/64.1.41 Clinical Trials in Duchenne Dystrophy
https://doi.org/10.1093/ptj/74.3.253 Facioscapulohumeral Dystrophy Natural History Study: Standardization of Testing Procedures and Reliability of Measurements
https://doi.org/10.1212/wnl.38.3.405 Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis
https://doi.org/10.1093/ptj/65.9.1339 Reliability of Goniometric Measurements in Patients with Duchenne Muscular Dystrophy
https://doi.org/10.1177/088307380101600104 Spasticity Management: An Overview
https://doi.org/10.1073/pnas.0708145104 Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle
https://doi.org/10.1038/mt.2008.149 Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
Role of astrocytes in the control of developing retinal vessels.
https://doi.org/10.1002/ana.410330114 Glycogen branching enzyme deficiency in adult polyglucosan body disease
https://doi.org/10.1097/01.mop.0000193294.94646.be Recent developments in tissue engineering and regenerative medicine
https://doi.org/10.3791/51586 Tissue Triage and Freezing for Models of Skeletal Muscle Disease
https://doi.org/10.1177/0883073810371001 Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular Dystrophy
https://doi.org/10.1016/j.ncl.2011.01.004 Pediatric Multiple Sclerosis
https://doi.org/10.1038/sj.gt.3302505 Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin
https://doi.org/10.1016/j.ymthe.2005.11.001 Gene Therapy Strategies for Duchenne Muscular Dystrophy Utilizing Recombinant Adeno-associated Virus Vectors
https://doi.org/10.1371/journal.pgen.1000958 The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
https://doi.org/10.1017/s1462399409001100 Emerging strategies for cell and gene therapy of the muscular dystrophies
https://doi.org/10.1016/j.ymthe.2005.04.001 Phenotypic Improvement of Dystrophic Muscles by rAAV/Microdystrophin Vectors Is Augmented by Igf1 Codelivery
https://doi.org/10.1042/bj20051965 Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein
https://doi.org/10.1016/j.mcn.2008.12.011 Truncated dystrophins can influence neuromuscular synapse structure
https://doi.org/10.1186/2044-5040-3-1 Sarcospan: a small protein with large potential for Duchenne muscular dystrophy
https://doi.org/10.1111/ddg.12909 Guidelines on dermatomyositis – excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology
https://doi.org/10.1002/ana.21213 Molecular consequences of dominant Bethlem myopathy collagen VI mutations
https://doi.org/10.1038/mt.2009.253 Dystrophin Delivery to Muscles of mdx Mice Using Lentiviral Vectors Leads to Myogenic Progenitor Targeting and Stable Gene Expression
https://doi.org/10.1177/1049909110369531 Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
https://doi.org/10.1177/104990910101800411 Marijuana in the management of amyotrophic lateral sclerosis
https://doi.org/10.1002/jmri.21941 MR imaging in Duchenne muscular dystrophy: Quantification of T1‐weighted signal, contrast uptake, and the effects of exercise
https://doi.org/10.1002/(sici)1097-4598(199606)19:6<777::aid-mus15>3.0.co;2-i Assessment of whole body composition with dual energy X-ray absorptiometry in Duchenne muscular dystrophy: Correlation of lean body mass with muscle function
https://doi.org/10.1111/j.1600-0854.2007.00622.x rAAV6‐Microdystrophin Rescues Aberrant Golgi Complex Organization in mdx Skeletal Muscles
https://doi.org/10.1093/hmg/ddm158 Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain
https://doi.org/10.1093/hmg/ddq334 Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice
https://doi.org/10.1111/j.1600-9657.2008.00745.x The use of calcium hydroxide and mineral trioxide aggregate on apexification of a replanted tooth: a case report
https://doi.org/10.1186/2044-5040-3-20 Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice
https://doi.org/10.1177/1049909109358420 Assessment and Management of Fatigue in Neuromuscular Disease
Early signs of gait deviation in Duchenne muscular dystrophy.
https://doi.org/10.1016/j.clineuro.2011.10.022 Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy
https://doi.org/10.1007/s00439-013-1302-7 Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes
https://doi.org/10.1016/j.nurx.2006.01.005 Therapeutics in Duchenne muscular dystrophy
https://doi.org/10.1002/ana.21556 Outcomes research in amyotrophic lateral sclerosis: Lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database
https://doi.org/10.1056/nejmcibr042889 Cachexia in Cancer — Zeroing in on Myosin
https://doi.org/10.1080/21678421.2017.1406953 A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013
https://doi.org/10.1038/s41467-018-05910-1 NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model
https://doi.org/10.4049/jimmunol.179.7.4939 Autoantibodies in Canine Masticatory Muscle Myositis Recognize a Novel Myosin Binding Protein-C Family Member
https://doi.org/10.1016/j.pmr.2011.11.016 Skeletal Muscle Edema in Muscular Dystrophy: Clinical and Diagnostic Implications
https://doi.org/10.1093/hmg/ddn301 Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin
https://doi.org/10.1038/s41467-019-12335-x In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
https://doi.org/10.1097/ede.0000000000000376 Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
https://doi.org/10.3174/ajnr.a1236 Endovascular Interventions following Intravenous Thrombolysis May Improve Survival and Recovery in Patients with Acute Ischemic Stroke: A Case-Control Study
https://doi.org/10.1172/jci.insight.123855 Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy